Northrop Grumman Corporation 10-Qquarter ended 2026-06-30

Executive Summary

Northrop Grumman’s deterrence and advanced-defense programs delivered 5.1% Q2 sales growth and a $105B backlog, strengthening revenue visibility. Profitability was less convincing: Q2 operating income fell 23%, partly because the prior year included a divestiture gain, while lower taxes cushioned earnings and contract overruns pressured Defense and Space Systems. H1 earnings increased 19%, but operating cash flow remained negative as working capital absorbed cash. The investment thesis rests on converting expanding B-21 and Sentinel commitments into profitable production without further losses or sustained cash consumption.

Key Financial Highlights

• Earnings comparability: The prior-year $231M training-services divestiture gain inflated Q2 operating income; lower pension-accounting operating adjustments also weighed on comparisons.
• Tax effects: Q2 effective tax rate fell to 6.3% from 17.7%, including a $115M benefit from remeasuring uncertain tax positions; H1’s rate fell to 10.4% from 17.5%. These benefits are not operating improvement.
• Cash-flow driver: H1 trade working-capital outflows of $2.52B explain much of the earnings-to-cash gap; lower cash tax payments helped OCF improve.
• Capital return: H1 repurchases were $68M vs $891M, but shares outstanding increased 0.05%, meaning repurchases did not shrink the share count. Dividends paid reached $684M; the quarterly dividend increased 7% to $2.47.
• Funding and asset composition: Long-term debt, net of current portion, was $14.4B; H1 interest expense was $323M. The $3.0B revolver was undrawn, while $17.4B of goodwill represented 34% of total assets.

Business Developments

• Demand and mix: Backlog increased 9.4% from year-end to $105B, including $58.7B unfunded; management expects 35% to convert within 12 months. Products generated 81% of H1 revenue, concentrating growth in hardware-intensive programs.
• B-21 expansion: Management expects to invest ≈$2.5B over multiple years to expand production capacity and rates. B-21, restricted programs and E-130J drove Aeronautics’ 15% H1 sales growth; much of its profit increase reflected the prior-year B-21 loss provision rather than fresh margin improvement.
• Sentinel and sector divergence: Sentinel requirements and design work added $7.6B to Q2 backlog; development remains cost-type, with later phases unpriced or unnegotiated. Mission Systems’ H1 operating income increased 16%, while Defense and Space earnings declined despite growing or broadly flat sales.

Risk Assessment

• Contract execution: Fixed-price contracts increased to 52% of Q2 external sales from 47%; GEM 63XL and SiAW incurred $91M and $68M unfavorable Q2 estimate adjustments, exposing earnings to further cost overruns.
• B-21 economics: ≈$2.0B of cumulative low-rate initial-production losses and a $1.0B remaining loss accrual leave returns sensitive to supplier negotiations, completion costs and unsettled future-lot terms.
• Government concentration: U.S. government customers accounted for 85% of sales, making appropriations delays, acquisition reforms and program changes consequential; unfunded backlog is not equivalent to committed funding.
• Cash and investment demands: Negative H1 FCF and planned B-21 investment compete with dividends and debt repayments for liquidity.
• Legal and environmental exposure: Environmental accruals were $552M, with $402M of reasonably possible additional costs; Bethpage litigation and the continuing civil pension-cost investigation create further unquantified exposure.

This 10-Q lists no risk factors of its own and refers to the annual report. The risks above come from the rest of this filing. Full list: the company's 10-Ks on SEC.

Strategic Outlook and Investor Actionables

Management is betting that deterrence modernization and expanded aircraft production will turn demand into sustained growth and better program returns. The opportunity is substantial backlog; the threat is that execution losses and cash requirements outpace its conversion.

• B-21 returns: Track the ≈$2.5B capacity investment against the $1.0B remaining loss accrual. Success means expanding production without renewed loss provisions; failure means higher estimated losses as capacity grows.
• Sentinel conversion: Follow the $7.6B backlog addition and subsequent contract pricing. Progress means awards converting into sales with controlled costs; deterioration means delays or unfavorable contract adjustments.
• Missile and launch execution: GEM 63XL’s $162M H1 unfavorable adjustment and SiAW’s $68M Q2 adjustment establish the baseline. Smaller adverse adjustments would support recovery; recurring charges would undermine growth economics.
• Cash delivery: Test whether H1 FCF of $(845)M improves as backlog converts. Lower working-capital outflows would validate earnings conversion; persistent cash consumption would constrain investment and capital returns.